PT-INR is ≥1.5 and <2.0, and the result of subsequent measurement performed in the judgement of a physician in charge within 24 hours shows an increasing trend, suggesting a high probability of a further increase exceeding 2.0.
← all excerpts
Intrauterine high-dose intravenous immunoglobulin therapy during pregnancy for women with a history of pregnancy ending in documented neonatal haemochromatosis (NH001): study protocol.
1
—
—